tavokinogene telseplasmid
Term · Oncology and biomedicine · MLC-T-ONC-016995
A DNA plasmid that encodes genes for both the p35 and p40 subunits of the heterodimeric human interleukin 12 (hIL-12) protein that are separated by an internal ribosome entry site (IRES) and under the control of a single cytomegalovirus (CMV) promoter, with potential immunomodulatory and antineoplastic activities. Upon administration via intratumoral injection and electroporation, the plasmid is introduced into human cells resulting in expression and highly-localized secretion of a functional IL-12 p70 protein into the tumor microenvironment (TME). IL-12 is a pro-inflammatory cytokine that plays a significant role in priming and maintaining T-helper (Th) cells, activating natural killer (NK) cells, and regulating the reactivation and survival of memory T cells (Tm). Increased levels of IL-12 in the TME may augment host immune response against tumor cells by inhibiting regulatory T cells (Tregs), T-helper 2 (Th2) responses, and myeloid-derived suppressor cells (MDSCs).
| Identifier | MLC-T-ONC-016995 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | tavo; IT-Tavo-EP; plasmid IL-12 pUMVC3-hIL-12-NGVL3 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016995",
"term": "tavokinogene telseplasmid",
"field": "Oncology and biomedicine",
"definition": "A DNA plasmid that encodes genes for both the p35 and p40 subunits of the heterodimeric human interleukin 12 (hIL-12) protein that are separated by an internal ribosome entry site (IRES) and under the control of a single cytomegalovirus (CMV) promoter, with potential immunomodulatory and antineoplastic activities. Upon administration via intratumoral injection and electroporation, the plasmid is introduced into human cells resulting in expression and highly-localized secretion of a functional IL-12 p70 protein into the tumor microenvironment (TME). IL-12 is a pro-inflammatory cytokine that plays a significant role in priming and maintaining T-helper (Th) cells, activating natural killer (NK) cells, and regulating the reactivation and survival of memory T cells (Tm). Increased levels of IL-12 in the TME may augment host immune response against tumor cells by inhibiting regulatory T cells (Tregs), T-helper 2 (Th2) responses, and myeloid-derived suppressor cells (MDSCs).",
"synonyms": [
"tavo",
"IT-Tavo-EP",
"plasmid IL-12 pUMVC3-hIL-12-NGVL3"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tavokinogene-telseplasmid/"
}
Record 16,018 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.